晚期胃肠道间质瘤-话题@MedSci

#晚期胃肠道间质瘤#

14篇内容 | 741人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1945583, encodeId=41be194558312, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, objectType=article, longId=735738, objectId=bcb3e35738dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcb3e35738dd, replyNumber=0, likeNumber=62, createdTime=2023-03-29, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcb3e35738dd, moduleTitle=J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcb3e35738dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945582, encodeId=68a3194558270, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后, objectType=article, longId=731132, objectId=d2bfe31132dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2bfe31132dd, replyNumber=0, likeNumber=53, createdTime=2022-08-17, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2bfe31132dd, moduleTitle=Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2bfe31132dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945581, encodeId=c177194558149, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后, objectType=article, longId=729655, objectId=e1f0e2965514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1f0e2965514, replyNumber=0, likeNumber=59, createdTime=2023-03-08, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1f0e2965514, moduleTitle=Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1f0e2965514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945580, encodeId=5fc719455806e, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, objectType=article, longId=729557, objectId=269be2955716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=269be2955716, replyNumber=0, likeNumber=65, createdTime=2022-10-20, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=269be2955716, moduleTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=269be2955716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945578, encodeId=ae2f19455e85b, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性, objectType=article, longId=217013, objectId=5eca21e01316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eca21e01316, replyNumber=0, likeNumber=40, createdTime=2021-12-19, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eca21e01316, moduleTitle=Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eca21e01316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945579, encodeId=39b319455e964, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效, objectType=article, longId=219181, objectId=102e219181e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=102e219181e4, replyNumber=0, likeNumber=57, createdTime=2022-05-13, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=102e219181e4, moduleTitle=Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=102e219181e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945576, encodeId=5d8919455e631, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益, objectType=article, longId=194393, objectId=2d8619439350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d8619439350, replyNumber=0, likeNumber=59, createdTime=2020-09-30, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d8619439350, moduleTitle=FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d8619439350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945577, encodeId=8bb119455e735, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究, objectType=article, longId=194645, objectId=1e85194645d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e85194645d2, replyNumber=0, likeNumber=54, createdTime=2020-09-06, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e85194645d2, moduleTitle=ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e85194645d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945574, encodeId=34b219455e458, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, objectType=article, longId=191054, objectId=22d01910546b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22d01910546b, replyNumber=0, likeNumber=43, createdTime=2021-02-03, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22d01910546b, moduleTitle=PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22d01910546b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945573, encodeId=e13819455e307, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Ripretinib治疗晚期胃肠道间质瘤取得NDA优先审查权, objectType=article, longId=188009, objectId=684e1880092a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=684e1880092a, replyNumber=0, likeNumber=32, createdTime=2020-10-20, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=684e1880092a, moduleTitle=Ripretinib治疗晚期胃肠道间质瘤取得NDA优先审查权, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=684e1880092a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945575, encodeId=dd5319455e5b0, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准, objectType=article, longId=194259, objectId=741619425993, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=741619425993, replyNumber=0, likeNumber=38, createdTime=2020-10-17, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=741619425993, moduleTitle=晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=741619425993)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945572, encodeId=43e919455e2cd, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=JAMA Oncol：达沙替尼治疗晚期胃肠道间质瘤效果如何？, objectType=article, longId=144602, objectId=d4eb14460254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4eb14460254, replyNumber=0, likeNumber=41, createdTime=2019-06-20, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4eb14460254, moduleTitle=JAMA Oncol：达沙替尼治疗晚期胃肠道间质瘤效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4eb14460254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945571, encodeId=670019455e140, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=ASCO2013：尼罗替尼用于晚期胃肠道间质瘤一线治疗不优于伊马替尼, objectType=article, longId=18971, objectId=37b5189e191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37b5189e191, replyNumber=0, likeNumber=36, createdTime=2014-01-31, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37b5189e191, moduleTitle=ASCO2013：尼罗替尼用于晚期胃肠道间质瘤一线治疗不优于伊马替尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37b5189e191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1945570, encodeId=f6aa19455e0ef, content=<a href='/topic/show?id=1729598e95c' target=_blank style='color:#2F92EE;'>#晚期胃肠道间质瘤#</a>, objectTitle=Ann Oncol：晚期胃肠道间质瘤不推荐停用伊马替尼后再次给药, objectType=article, longId=9062, objectId=f7679062a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7679062a7, replyNumber=0, likeNumber=41, createdTime=2013-07-30, rootId=0, userName=ZGMFX24A, userId=7fb6449, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7679062a7, moduleTitle=Ann Oncol：晚期胃肠道间质瘤不推荐停用伊马替尼后再次给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f7679062a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期胃肠道间质瘤

2020-05-29

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

J Clin Oncol：瑞派替尼 vs 舒尼替尼后线治疗晚期胃肠道间质瘤

2023-03-29

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Clin Cancer Res：瑞普替尼四线治疗可显著改善晚期胃肠道间质瘤患者的预后

2022-08-17

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Clin Cancer Res：瑞普替尼作为四线+治疗可显著改善中国晚期胃肠道间质瘤患者的预后

2023-03-08

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后

2022-10-20

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Clin Cancer Res：3期| 瑞普替尼治疗晚期胃肠道间质瘤的临床活性

2021-12-19

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Clin Cancer Res：瑞普替尼在携带KIT/PDGFRA突变的晚期胃肠道间质瘤患者中的显著疗效

2022-05-13

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

FDA批准Ripretinib用于四线晚期胃肠道间质瘤治疗！再鼎医药持有中国权益

2020-09-30

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

ASCO 2020：MEK162（贝美替尼）联合伊马替尼治疗晚期胃肠道间质瘤II期临床研究

2020-09-06

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

PDGFRα靶向新药avapritinib在中国台湾申请用于治疗晚期胃肠道间质瘤成人患者

2021-02-03

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Ripretinib治疗晚期胃肠道间质瘤取得NDA优先审查权

2020-10-20

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

晚期胃肠道间质瘤（GIST）患者的新希望！四线疗法Ripretinib获FDA批准

2020-10-17

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

JAMA Oncol：达沙替尼治疗晚期胃肠道间质瘤效果如何？

2019-06-20

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

ASCO2013：尼罗替尼用于晚期胃肠道间质瘤一线治疗不优于伊马替尼

2014-01-31

ZGMFX24A (审核中...)

前往app查看评论内容

#晚期胃肠道间质瘤#

Ann Oncol：晚期胃肠道间质瘤不推荐停用伊马替尼后再次给药

2013-07-30

科室
- - 订阅+
  - 更多科室
工具
服务